ANXA2 and breast carcinoma: Our analysis showed that AnxA2 levels were significantly high in serum samples of breast cancer patients (n = 162; 11.18 ± 0.505 ng/mL, p < 0.0001) compared to normal healthy females (n = 65; 6.616 ± 0.544 ng/mL) (Figure 2A).